Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PLAVIX for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 14 adverse event reports in the FDA FAERS database where PLAVIX was used for Atrial fibrillation.

Most Reported Side Effects for PLAVIX

Side Effect Reports % Deaths Hosp.
Gastrointestinal haemorrhage 723 33.8% 35 45
Ulcer haemorrhage 400 18.7% 22 10
Haemorrhage 362 16.9% 33 14
Multiple injuries 320 15.0% 26 1
Cerebral haemorrhage 130 6.1% 38 12
Cerebrovascular accident 96 4.5% 15 14
Myocardial infarction 84 3.9% 10 12
Anaemia 43 2.0% 1 38
Death 41 1.9% 41 3
Dyspnoea 28 1.3% 1 16
Thrombotic thrombocytopenic purpura 27 1.3% 3 1
Nausea 25 1.2% 0 9
Asthenia 23 1.1% 2 14
Dizziness 23 1.1% 1 13
Epistaxis 20 0.9% 0 10

Other Indications for PLAVIX

Product used for unknown indication (839) Stent placement (68) Prophylaxis (64) Cerebrovascular accident (37) Coronary arterial stent insertion (31) Thrombosis prophylaxis (30) Myocardial infarction (27) Acute coronary syndrome (18) Transient ischaemic attack (14) Coronary artery disease (13)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

PLAVIX Full Profile All Atrial fibrillation Drugs PLAVIX Demographics PLAVIX Timeline